Skip to Content

Beryl Lieff Benderly

Most Medical Schools Now Have “Strong” Conflict-of-Interest Policies, Survey Shows

More than two thirds of U.S. medical schools rate a grade of B or better for their policies regulating faculty relations with pharmaceutical companies, according to survey results released on 8 March by the American Medical Student Association

Two schools — University of South Dakota Sanford School of Medicine and Florida State University College of Medicine — prohibit campus visits by pharmaceutical company sales reps.  A quarter of schools have shown improvement in their policies over the past 2 years and Harvard has moved from having no policies in 2008 to receiving an A in the current report.  Seventeen schools prohibit or “severely” limit work with company speakers bureaus.

Full details of the survey results are here.